| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/07/2008 | US20080031966 Sustained release compositions for delivery of pharmaceutical proteins |
| 02/07/2008 | US20080031957 Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin |
| 02/07/2008 | US20080031956 Bioimplant formulation |
| 02/07/2008 | US20080031954 Modulation of angiogenesis by a-beta peptide fragments |
| 02/07/2008 | US20080031952 Nucleic Acid Comprising a Sequence Encoding a Modified Glutenin Polypeptide |
| 02/07/2008 | US20080031923 Biologic Replacement for Fibrin Clot |
| 02/07/2008 | US20080031919 Vasoocclusive microcoil including a radiopaque metal wire, the outer surface of which has pores with complex shapes containing a plastic agent that acts to accelerate healing once the coil is in place |
| 02/07/2008 | US20080031916 Dendrimer cross-linked collagen |
| 02/07/2008 | US20080031913 Method for manufacturing biomedical filler material rich-contained with growth factor |
| 02/07/2008 | US20080031912 Method for controlling cell migration on a surface |
| 02/07/2008 | US20080031907 Cosmetic and pharmaceutical foam |
| 02/07/2008 | US20080031898 Compositions and methods to increase the effect of a neurotoxin treatment |
| 02/07/2008 | US20080031892 Extracellular immune stimulating agents from fungus of the genus Lentinus with high level of immune modulating activity; acquired immunodeficiency syndrome; mixture of polysaccharides comprises the monosaccharides galactose, mannose and glucose |
| 02/07/2008 | US20080031888 Tumor antigens |
| 02/07/2008 | US20080031886 Viruses for the treatment of cellular proliferative disorders |
| 02/07/2008 | US20080031885 Use of Goat Serum for Veterinary Treatment |
| 02/07/2008 | US20080031883 Condition-dependent, multiple target delivery system |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031879 Wound healing agents; antiscarring; regeneration: antifibrotic agents: treatment of keloids or hypertrophic scars |
| 02/07/2008 | US20080031876 Use preventing transplant rejection, treating autoimmune diseases, and in leukocyte typing and FAC sorting; CD28/CTLA4Ig fusion proteins |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031870 Method of proliferation in neurogenic regions |
| 02/07/2008 | US20080031869 Pain relief composition |
| 02/07/2008 | US20080031868 Human lysozyme medicine, its manufacturing method and application thereof |
| 02/07/2008 | US20080031867 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| 02/07/2008 | US20080031866 Method for modulating the pharmacokinetics and metabolism of a therapeutic agent |
| 02/07/2008 | US20080031865 Product and process for liquefaction of mucus or sputum |
| 02/07/2008 | US20080031864 PEG-Urate Oxidase Conjugates and Use Thereof |
| 02/07/2008 | US20080031863 Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease |
| 02/07/2008 | US20080031862 Mitochondria-targeted antioxidants |
| 02/07/2008 | US20080031861 Dietary supplements containing natural ingredients |
| 02/07/2008 | US20080031860 Compositions Comprising Pantothenic Acid or Derivatives Thereof and Their Use for Stimulating Appetite |
| 02/07/2008 | US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides |
| 02/07/2008 | US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | US20080031850 Tissue Regeneration Method |
| 02/07/2008 | US20080031849 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 02/07/2008 | US20080031833 Combined energy and topical composition application for regulating the condition of mammalian skin |
| 02/07/2008 | US20080031818 Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases |
| 02/07/2008 | US20080031813 Targeted Combination Immunotherapy of Cancer and Infectious Diseases |
| 02/07/2008 | US20080031812 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates, thereof, compositions and methods of synthesis and use |
| 02/07/2008 | US20080029084 Device for improved peptide delivery |
| 02/07/2008 | US20080029083 Ejection liquid and ejection method |
| 02/07/2008 | DE4435392B4 Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF Process for the separation of vWF in high molecular weight vWF and low molecular weight vWF |
| 02/07/2008 | DE102006036285A1 Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms Fractions of whey permeate and their use for the prevention and treatment of type 2 diabetes and the metabolic syndrome |
| 02/07/2008 | CA2693378A1 Myostatin antagonists |
| 02/07/2008 | CA2693326A1 Gm-csf and il-15 fusokines and methods for modulation of the immune response |
| 02/07/2008 | CA2660052A1 Compositions and methods for the modulation of jnk proteins |
| 02/07/2008 | CA2660029A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 02/07/2008 | CA2659892A1 Mitochondria-targeted antioxidants |
| 02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
| 02/07/2008 | CA2659846A1 Parathyroid hormone analogues and methods of use |
| 02/07/2008 | CA2659778A1 Cleavage of bip by subtilase cytotoxin |
| 02/07/2008 | CA2659681A1 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin .alpha.5.beta.1, having proangiogenic activity |
| 02/07/2008 | CA2659612A1 Implantable preparation, useful more particularly for tissue complement and cicatrisation |
| 02/07/2008 | CA2659149A1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 02/07/2008 | CA2658972A1 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 02/07/2008 | CA2658800A1 Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and nonfucosylated forms |
| 02/07/2008 | CA2658751A1 Kit and methods of treatment of an intervertebral disc |
| 02/07/2008 | CA2658340A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/07/2008 | CA2653438A1 Fusion peptide for inhibiting interaction of neuronal nmda receptor (nmdar) and nmdar interacting proteins |
| 02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/06/2008 | EP1884521A1 Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| 02/06/2008 | EP1884520A2 Daptomycin analogs as antibacterial agents |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1884246A1 Cystatin from nematodes in the treatment of autoimmune or allergic diseases |
| 02/06/2008 | EP1884235A1 Myeloerythroid progenitor differentiation inducer |
| 02/06/2008 | EP1883708A1 Genemap of the human genes associated with crohn's disease |
| 02/06/2008 | EP1883699A2 Non-viral vector system for transporting nucleic acid into the lungs |
| 02/06/2008 | EP1883649A2 Hiv vif mutants |
| 02/06/2008 | EP1883421A2 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 02/06/2008 | EP1883419A2 Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use |
| 02/06/2008 | EP1883418A2 Sclerostin and the inhibition of wnt signaling and bone formation |
| 02/06/2008 | EP1883417A2 Peptides, derivatives and analogs thereof, and methods of using same |
| 02/06/2008 | EP1883395A2 Lipid construct for delivery of interferon to a mammal |
| 02/06/2008 | EP1883394A2 Lipid construct for delivery of insulin to a mammal |
| 02/06/2008 | EP1833495B1 Dermatologic use of milk proteins |
| 02/06/2008 | EP1725868A4 Methods of using high affinity atiii variants |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP1196449B1 A method of modulating integrin mediated cellular activity and agents useful for same |
| 02/06/2008 | CN101120250A VGP peptide fragments as biomarkers for schizophrenic and bipolar disorders |
| 02/06/2008 | CN101120022A Methods for treating autoimmune disorders |
| 02/06/2008 | CN101120015A Interleukin-15 antagonist peptide |
| 02/06/2008 | CN101120014A Modulation of ovulation |
| 02/06/2008 | CN101120012A Metabolites of cyclosporin analogs |
| 02/06/2008 | CN101119749A Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 02/06/2008 | CN101119745A Lectin compositions and methods for modulating an immune response to an antigen |
| 02/06/2008 | CN101119743A Immunopotentiating agent |
| 02/06/2008 | CN101119742A Pharmaceutical composition for the prevention and treatment of cancer |
| 02/06/2008 | CN101119741A Modified beta thymosin peptides |
| 02/06/2008 | CN101117644A Diagnostics and therapeutics for glaucoma |
| 02/06/2008 | CN101117635A Fusion expression of PTD,HIF ODD and tumour inhibitory gene and uses thereof |
| 02/06/2008 | CN101117630A Preparation method of nattokinase powder and natto Brazil mushroom capsule |
| 02/06/2008 | CN101116744A Combination neisserial compositions |
| 02/06/2008 | CN101116743A Cold treating medicine |
| 02/06/2008 | CN101116742A Non-aqueous polar aprotic peptide formulations comprising lhrh-related compounds |
| 02/06/2008 | CN101116512A Enteral feeding solutions contain an alkyl paraben to inhibit growth of micro-organisms in the enteral tube |
| 02/06/2008 | CN100366742C IL-2 selective agonists and antagonists |
| 02/06/2008 | CN100366633C Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |